From: A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
A | |||||||
Univariable | 1st quartile | 3rd quartile | Difference | OR | 95% CI. | p value | |
ProCUrE | − 2.0006 | − 1.0828 | 0.91789 | 1.58*** | 1.28 | 1.96 | < 0.0001 |
APC | 0 | 0.37652 | 0.37652 | 1.24*** | 1.10 | 1.39 | 0.0003 |
HOXD3 | 0.43965 | 5.2043 | 4.7646 | 1.54*** | 1.24 | 1.90 | < 0.0001 |
GSTP1 | 0 | 0.1216 | 0.1216 | 1.06** | 1.02 | 1.10 | 0.0013 |
KLK10 | 0 | 0.12665 | 0.12665 | 1.07** | 1.02 | 1.11 | 0.0048 |
TGFβ2 | 0 | 0.309 | 0.309 | 1.03* | 1.00 | 1.06 | 0.0481 |
TBX15 | 0 | 0.21295 | 0.21295 | 1.16*** | 1.08 | 1.24 | < 0.0001 |
PSA | 4.565 | 10.48 | 5.915 | 1.98*** | 1.46 | 2.68 | < 0.0001 |
Age | 59 | 71 | 12 | 1.66** | 1.13 | 2.45 | 0.0105 |
PSA density | 0.09 | 0.2 | 0.11 | 2.35*** | 1.51 | 3.68 | 0.0002 |
Prostate volume | 40 | 70 | 30 | 0.70 | 0.47 | 1.06 | 0.0926 |
B | |||||||
Multivariable | OR | 95% CI. | p value | ||||
ProCUrE | 1.358* | 1.051 | 1.754 | 0.0194 | |||
PSA | 0.816 | 0.373 | 1.785 | 0.6108 | |||
Age | 2.718** | 1.295 | 5.707 | 0.0082 | |||
PSA density | 2.878** | 1.455 | 5.694 | 0.0024 |